BIOMAT Database Logo BIOMAT Database Logo

Decreased severe hypoglycemia frequency during intraperitoneal insulin infusion using programmable implantable pumps. Evadiac Study Group. 1996

N Jeandidier, and J L Selam, and E Renard, and B Guerci, and V Lassman-Vague, and L Rocher, and H Hanaire-Broutin

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007332 Insulin Infusion Systems Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor. Pancreas, Artificial Endocrine,Programmable Implantable Insulin Pump,beta Cell, Artificial,Implantable Programmable Insulin Pump,Insulin Pump, Programmable Implantable,Pump, Programmable Implantable Insulin,Artificial Endocrine Pancreas,Artificial beta Cell,Artificial beta Cells,Cell, Artificial beta,Cells, Artificial beta,Endocrine Pancreas, Artificial,Infusion System, Insulin,Infusion Systems, Insulin,Insulin Infusion System,System, Insulin Infusion,Systems, Insulin Infusion,beta Cells, Artificial
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N Jeandidier, and J L Selam, and E Renard, and B Guerci, and V Lassman-Vague, and L Rocher, and H Hanaire-Broutin
Immunogenicity of intraperitoneal insulin infusion using programmable implantable devices.
May 1995, Diabetologia,
N Jeandidier, and J L Selam, and E Renard, and B Guerci, and V Lassman-Vague, and L Rocher, and H Hanaire-Broutin
Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs.
March 1995, Diabetes care,
N Jeandidier, and J L Selam, and E Renard, and B Guerci, and V Lassman-Vague, and L Rocher, and H Hanaire-Broutin
French multicentre experience of implantable insulin pumps. The EVADIAC Study Group. Evaluation of Active Implants in Diabetes Society.
February 1994, Lancet (London, England),
N Jeandidier, and J L Selam, and E Renard, and B Guerci, and V Lassman-Vague, and L Rocher, and H Hanaire-Broutin
Immunogenicity of long-term intraperitoneal insulin administration with implantable programmable pumps. Metabolic consequences.
April 1995, Diabetes care,
N Jeandidier, and J L Selam, and E Renard, and B Guerci, and V Lassman-Vague, and L Rocher, and H Hanaire-Broutin
Systematic review: continuous intraperitoneal insulin infusion with implantable insulin pumps for diabetes mellitus.
January 2014, Acta diabetologica,
N Jeandidier, and J L Selam, and E Renard, and B Guerci, and V Lassman-Vague, and L Rocher, and H Hanaire-Broutin
Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps.
January 1993, Diabete & metabolisme,
N Jeandidier, and J L Selam, and E Renard, and B Guerci, and V Lassman-Vague, and L Rocher, and H Hanaire-Broutin
Reproducibility of plasma insulin kinetics during intraperitoneal insulin treatment by programmable pumps.
September 2003, Diabetes & metabolism,
N Jeandidier, and J L Selam, and E Renard, and B Guerci, and V Lassman-Vague, and L Rocher, and H Hanaire-Broutin
Diagnostic procedures for catheter malfunction in programmable implantable intraperitoneal insulin infusion devices.
January 1995, Diabetes care,
N Jeandidier, and J L Selam, and E Renard, and B Guerci, and V Lassman-Vague, and L Rocher, and H Hanaire-Broutin
Influence of abdominal location of the catheter on the efficacy of intraperitoneal insulin infusion using implantable and programmable pumps in type I diabetes.
June 1992, Transplantation proceedings,
N Jeandidier, and J L Selam, and E Renard, and B Guerci, and V Lassman-Vague, and L Rocher, and H Hanaire-Broutin
Implantable programmable insulin pumps for the treatment of diabetes.
September 1992, Archives of surgery (Chicago, Ill. : 1960),
Copied contents to your clipboard!